Abstract
Objective
To elucidate the symptoms that patients with glaucoma voluntarily report and to determine
the correlation between the symptoms and the stage of glaucoma.
Design
Retrospective case series.
Participants
A total of 401 patients who presented to the Glaucoma Service from January 2012 through
November 2013.
Methods
The Wills Eye Hospital Glaucoma Research Center retrospectively reviewed the medical
records of patients who visited the Glaucoma Service from January 2012 through November
2013. We recorded any symptom written in the charts at the last eligible visit of
each patient. The patients were classified by different stages according to the mean
deviation of the Octopus visual field.
Results
We analyzed 401 patients, who were graded with mild (n = 170), moderate (n = 106),
or severe (n = 125) visual-field loss. The majority of patients did not report any
symptoms (56.0%); 24.2% reported ocular surface disease (OSD) symptoms; and 25.8%
reported visual complaints. The presence of symptoms positively correlated with the
severity of glaucoma (p = 0.01) and the number of surgeries (p = 0.02). Burning/smarting/stinging and blurry vision showed a positive correlation
with the severity of glaucoma (p < 0.05). Older patients (> 69 years) showed a significant increase in OSD symptoms
(p = 0.001).
Conclusions
About one-fourth of the patients with glaucoma reported visual complaints, and another
fourth reported OSD symptoms, both of which correlated with glaucoma severity. The
high prevalence of OSD symptoms suggests that patients should be specifically questioned
about these symptoms and treated as indicated. This information is of value particularly
in the new era of nonpreserved glaucoma medications.
Résumé
Objet
Élucidation des symptômes du glaucome que les patients signalent volontairement et
détermination de la corrélation entre les symptômes et l’étape du glaucome.
Nature
Séries rétrospectives de cas.
Participants
401 patients qui s’étaient présentés au Service du glaucome de janvier 2012 à novembre
2013.
Méthodes
Le Centre Wills Eye de recherche oculaire en glaucome a revu rétrospectivement les
dossiers médicaux de patients qui avaient visité le Service du Glaucome entre janvier
2012 et novembre 2013. Nous avons relevé tout symptôme inscrit dans les dossiers dans
la dernière visite éligible de chaque patient. Les sujets furent classifiés selon
diverses étapes selon la moyenne de déviation du champ visuel Octopus.
Résultats
Nous avons analysé 401 patients, dont la perte visuelle a été classée légère (N=170),
modérée (N=106) ou grave (N=125). La majorité des patients n’avait pas signalé de
symptôme (56,0 %), 24,2 % avaient signalé des symptômes de maladie de la surface oculaire
(MSO) et 25,8 % avaient exprimé des plaintes visuelles. La présence de symptômes était
en corrélation avec la gravité du glaucome (p = 0,01) et le nombre de chirurgies (p = 0,02). Les brûlements/picotements/piquements et la vision trouble montraient une
corrélation positive avec la gravité du glaucome (p < 0,05). Les patients plus âgés (>69 ans) présentèrent une hausse significative des
symptômes de MSO (p = 0,001).
Conclusion
Environ le quart des patients atteints du glaucome a signalé des plaintes visuelles
et un autre quart a fait état de symptômes de MSO, les deux groupes étant reliés à
la gravité du glaucome. La forte prévalence des symptômes de MSO suggère que les patients
devraient être interrogés particulièrement sur ces symptômes et traités tel qu’indiqué.
Cette information est particulièrement valable dans la nouvelle ère de médication
du glaucome sans agent de conservation.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of OphthalmologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The Impact of Vision Impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and Rasch analysis.Invest Ophthalmol Vis Sci. 2007; 48: 1001-1006
- The Glaucoma Symptom Scale: a brief index of glaucoma-specific symptoms.Arch Ophthalmol. 1998; 116: 861-866
- Visual field staging systems in glaucoma and the activities of daily living.Am J Ophthalmol. 2012; 154: e443
- National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire.Arch Ophthalmol. 2001; 119: 1050-1058
- Glaucoma patients’ assessment of their visual function and quality of life.Trans Am Ophthalmol Soc. 2001; 99: 301-317
- Evaluation of quality of life for patients with glaucoma.Am J Ophthalmol. 2006; 141: S3-14
- Are standard instruments valid for the assessment of quality of life and symptoms in glaucoma?.Optom Vis Sci. 2007; 84: 789-796
- Which quality of life score is best for glaucoma patients and why?.BMC Ophthalmol. 2008; 8: 2
Khadka J, McAlinden C, Craig JE, Fenwick EK, Lamoureux EL, Pesudovs K. Identifying content for the Glaucoma-specific Item Bank to Measure Quality-of-life Parameters [published online April 2, 2013]. J Glaucoma.
- Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey.Ophthalmology. 2003; 110: 1484-1490
- Prevalence of primary glaucoma in an urban south Indian population.Indian J Ophthalmol. 1998; 46: 81-86
- Glaucoma and its treatment: a review.Am J Health Syst Pharm. 2005; 62: 691-699
- Quality of life in glaucoma and its relationship with visual function.J Glaucoma. 2003; 12: 139-150
- Associations between glaucomatous visual field loss and participation in activities of daily living.Clin Experiment Ophthalmol. 2003; 31: 482-486
- Influence of glaucomatous visual field loss on health-related quality of life.Arch Ophthalmol. 1997; 115: 777-784
- Formulas for conversion between Octopus and Humphrey threshold values and indices.Graefes Arch Clin Exp Ophthalmol. 1995; 233: 627-634
- Prevalence of ocular surface disease in glaucoma patients.J Glaucoma. 2008; 17: 350-355
- Dry eye syndrome-related quality of life in glaucoma patients.Eur J Ophthalmol. 2009; 19: 572-579
- Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.Cornea. 2010; 29: 618-621
- Ocular surface disease and quality of life in patients with glaucoma.Am J Ophthalmol. 2012; 153: e2
Abegão Pinto L, Vandewalle E, Gerlier L, Stalmans I; CosoptUD Switch Study Group. Improvement in glaucoma patient quality of life by therapy switch to preservative-free timolol/dorzolamide fixed combination [published online December 21, 2013]. Ophthalmologica. 2014;231:166-171.
- Preservative-free treatment in glaucoma: who, when, and why.Eur J Ophthalmol. 2013; 23: 518-525
- The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma.Ophthalmology. 2001; 108: 1954-1965
- Quality of life of medically versus surgically treated glaucoma patients.J Glaucoma. 2013; 22: 369-373
- Statistical Power Analysis for the Behavioral Sciences.2nd ed. Erlbaum, Hillsdale, NJ1988
Article Info
Publication History
Accepted:
July 24,
2014
Received in revised form:
July 10,
2014
Received:
April 23,
2014
Identification
Copyright
© 2014 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.
